文献速递主动脉疾病

开窗Anaconda内移植物用于复杂腔内动脉瘤修复时的肢体通畅率发生率及预测因素

Incidence and predictive factors for endograft limb patency of the fenestrated Anaconda endograft used for complex endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2021-12-15

本研究基于11个中心2010年6月至2018年5月共335例择期开窗Anaconda内移植物修复复杂胸腹主动脉瘤的患者,中位随访14.3个月。随访期间30例(9.0%)发生肢体闭塞,女性性别是肢体闭塞的显著预测因素,而瘤囊内血栓负荷较高和髂动脉成角较大似乎具有保护作用。

要点

  • 335例中30例(9.0%)发生肢体闭塞,30天、1年、5年免于肢体闭塞率分别为98.5%、91.2%、81.7%。
  • 女性性别是肢体闭塞的显著预测因素(OR 3.27,95%CI 1.28-8.34,P=0.01)。
  • 瘤囊内血栓比例较高和髂动脉成角较大似乎对肢体闭塞具有保护作用。

核心结论

  • 肢体闭塞仍是开窗Anaconda内移植物耐久性的重要障碍,尤其对于女性患者。
  • 较高的动脉瘤血栓负荷和较大程度的髂动脉成角似乎对肢体闭塞具有保护作用,而多数肢体闭塞未发现明显原因。

研究设计与样本

  • 回顾性多中心研究,纳入2010年6月至2018年5月在11个参与中心接受择期开窗Anaconda内移植物(Terumo Aortic,Inchinnan,英国)修复复杂胸腹主动脉瘤的335例患者,中位随访14.3个月(四分位距27.4个月)。

主要发现

  • 335例中30例(9.0%)随访期间发生肢体闭塞,30天、1年、5年免于肢体闭塞率分别为98.5%、91.2%、81.7%。
  • 87%的病例未记录到肢体闭塞的明显原因;原发性闭塞36.7%发生在30天内,80.0%发生在1年内。
  • 30例中23例(77%)接受了闭塞相关再干预,7例(23.3%)接受保守治疗;30天、1年、5年免于肢体闭塞相关再干预率分别为97.8%、93.2%、88.6%。
  • 继发通畅率1个月后为91.3%,1年和5年后均为86.2%。
  • 女性性别是肢体闭塞的显著预测因素(OR 3.27,95%CI 1.28-8.34,P=0.01)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the present study, we have described the incidence, risk factors, and outcomes of treatment of limb occlusion for patients who had undergone treatment of complex thoracoabdominal aortic aneurysms with the fenestrated Anaconda endograft (Terumo Aortic, Inchinnan, UK). METHODS: Between June 2010 and May 2018, 335 patients had undergone elective fenestrated aortic aneurysm repair at 11 participating centers using the fenestrated Anaconda endograft with a median follow-up of 14.3 months (interquartile range, 27.4 months). The primary outcome measure was freedom from limb occlusion. The secondary outcome measures were freedom from limb-related reintervention, secondary patency, and the risk factors associated with limb occlusion. RESULTS: Of the 335 patients, 30 (9.0%) had presented with limb occlusion during follow-up with a freedom from limb occlusion rate of 98.5%, 91.2%, and 81.7% at 30 days and 1 and 5 years, respectively. In 87% of the cases, no obvious cause for limb occlusion was documented. Primary occlusion had occurred within 30 days in 36.7% and within 1 year in 80.0%. Of the 30 patients, 23 (77%) had undergone an occlusion-related reintervention and 7 (23.3%) had been treated conservatively. The freedom from limb occlusion-related reintervention at 30 days and 1 and 5 years was 97.8%, 93.2%, and 88.6%, respectively. Secondary patency was 91.3% after 1 month and 86.2% after 1 and 5 years. Female sex (odds ratio [OR], 3.27; 95% confidence interval [CI], 1.28-8.34; P = .01) was a statistically significant predictor for limb occlusion. A greater proportion of thrombus in the aneurysm sac appeared to be protective for limb occlusion (0% vs <25%: OR, 0.22; 95% CI, 0.07-0.63; P = .01; 0% vs 25%-50%: OR, 0.20; 95% CI, 0.07-0.57; P = .00; and 0% vs >50%: OR, 0.08; 95% CI, 0.02-0.38; P = .00), as did iliac angulation (OR, 0.99; 95% CI, 0.98-1.00; P = .04). CONCLUSIONS: Limb occlusion remains a significant impediment of endograft durability for patients treated with the fenestrated Anaconda endograft, especially for female patients. In contrast, a high aneurysmal thrombus load and a high degree of iliac angulation appeared to be protective for limb occlusion, for which no obvious cause could be identified.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Leeuwerke SJG, de Niet A, Geelkerken RH, et al. Incidence and predictive factors for endograft limb patency of the fenestrated Anaconda endograft used for complex endovascular aneurysm repair. J Vasc Surg. 2021. PMID: 34921964. doi:10.1016/j.jvs.2021.11.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。